Annual Operating Expenses
$285.42 M
+$112.55 M+65.11%
December 31, 2024
Summary
- As of March 10, 2025, AKRO annual total operating expenses is $285.42 million, with the most recent change of +$112.55 million (+65.11%) on December 31, 2024.
- During the last 3 years, AKRO annual operating expenses has risen by +$184.54 million (+182.92%).
- AKRO annual operating expenses is now at all-time high.
Performance
AKRO Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$78.03 M
-$3.68 M-4.50%
December 31, 2024
Summary
- As of March 10, 2025, AKRO quarterly total operating expenses is $78.03 million, with the most recent change of -$3.68 million (-4.50%) on December 31, 2024.
- Over the past year, AKRO quarterly operating expenses has dropped by -$3.68 million (-4.50%).
- AKRO quarterly operating expenses is now -4.50% below its all-time high of $81.70 million, reached on September 30, 2024.
Performance
AKRO Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
AKRO Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +65.1% | -4.5% |
| 3 y3 years | +182.9% | +140.5% |
| 5 y5 years | +525.2% | +381.0% |
AKRO Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +182.9% | -4.5% | +206.9% |
| 5 y | 5-year | at high | +525.2% | -4.5% | +530.3% |
| alltime | all time | at high | +1971.6% | -4.5% | >+9999.0% |
Akero Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $285.42 M(+65.1%) | $78.03 M(-4.5%) |
| Sep 2024 | - | $81.70 M(+24.3%) |
| Jun 2024 | - | $65.74 M(+9.7%) |
| Mar 2024 | - | $59.95 M(-3.1%) |
| Dec 2023 | $172.87 M(+50.1%) | $61.87 M(+32.7%) |
| Sep 2023 | - | $46.62 M(+30.8%) |
| Jun 2023 | - | $35.63 M(+23.9%) |
| Mar 2023 | - | $28.75 M(+13.1%) |
| Dec 2022 | $115.16 M(+14.1%) | $25.42 M(-29.6%) |
| Sep 2022 | - | $36.09 M(+30.8%) |
| Jun 2022 | - | $27.59 M(+5.9%) |
| Mar 2022 | - | $26.05 M(-19.7%) |
| Dec 2021 | $100.89 M | $32.44 M(+33.2%) |
| Sep 2021 | - | $24.35 M(-15.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $28.97 M(+91.5%) |
| Mar 2021 | - | $15.13 M(-49.2%) |
| Dec 2020 | $80.15 M(+75.6%) | $29.78 M(+38.3%) |
| Sep 2020 | - | $21.54 M(+30.9%) |
| Jun 2020 | - | $16.45 M(+32.9%) |
| Mar 2020 | - | $12.38 M(-23.7%) |
| Dec 2019 | $45.65 M(+231.3%) | $16.22 M(-0.5%) |
| Sep 2019 | - | $16.31 M(+114.3%) |
| Jun 2019 | - | $7.61 M(+38.0%) |
| Mar 2019 | - | $5.51 M(+85.7%) |
| Dec 2018 | $13.78 M | $2.97 M(+71.9%) |
| Sep 2018 | - | $1.73 M(-80.1%) |
| Jun 2018 | - | $8.66 M(+1957.5%) |
| Mar 2018 | - | $421.00 K |
FAQ
- What is Akero Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Akero Therapeutics?
- What is Akero Therapeutics annual operating expenses year-on-year change?
- What is Akero Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Akero Therapeutics?
- What is Akero Therapeutics quarterly operating expenses year-on-year change?
What is Akero Therapeutics annual total operating expenses?
The current annual operating expenses of AKRO is $285.42 M
What is the all time high annual operating expenses for Akero Therapeutics?
Akero Therapeutics all-time high annual total operating expenses is $285.42 M
What is Akero Therapeutics annual operating expenses year-on-year change?
Over the past year, AKRO annual total operating expenses has changed by +$112.55 M (+65.11%)
What is Akero Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of AKRO is $78.03 M
What is the all time high quarterly operating expenses for Akero Therapeutics?
Akero Therapeutics all-time high quarterly total operating expenses is $81.70 M
What is Akero Therapeutics quarterly operating expenses year-on-year change?
Over the past year, AKRO quarterly total operating expenses has changed by -$3.68 M (-4.50%)